Document is current

Article History

Received: 5 May 2023

Accepted: 19 August 2024

First Online: 20 September 2024

Declarations

:

: The study protocol was approved by the Zhongshan Ophthalmic Center, Sun Yat-sen University (Ethical NO.2019KYPJ076), Shenzhen Eye Hospital (NO.2019KYPJ076), Xiamen Eye Center of Xiamen University (NO.IRB2021-YX-049-01), Xi’an People’s Hospital (NO.IRB2021-YX-049-01), Tianjin Medical University General Hospital (NO.IRB2021-YX-049-01), and was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation of Good Clinical Practice guidelines and applicable Chinese law. Informed consent was obtained from all subjects involved in the study.

: Written informed consent for publication of their clinical images was obtained from the patient.

: None of the authors has any conflicts of interest to disclose except for authors of Vesber Vitreous Institute. Vesber Vitreous Institute is a research center established by Guangzhou Vesber Biotechnology Co. Ltd. The institute mainly focuses on the research and translation of clinical medical results in ophthalmology, and the authors Qianying Gao, Siqi Qiao, Yingyu Wang and Yuanyuan Liu are all workers from the institute. The authors have no competing interests as defined by BMC, or other interests that might be perceived to influence the results and/or discussion reported in this paper.